Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplant”

684 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 684 results

Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT02703779
What this trial is testing

Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Siddhartha Ganguly 101
Testing effectiveness (Phase 2)Study completedNCT01105403
What this trial is testing

Exploratory Study on POL6326 in Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Polyphor Ltd. 21
Not applicableNo Longer AvailableNCT00720603
What this trial is testing

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma
Genzyme, a Sanofi Company
Not applicableActive Not RecruitingNCT05145062
What this trial is testing

Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.

Who this might be right for
Blood and Lymphatic Diseases
Sangamo Therapeutics 8
Early research (Phase 1)Active Not RecruitingNCT01044069
What this trial is testing

Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Who this might be right for
LeukemiaAcute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 93
Not applicableStudy completedNCT04364256
What this trial is testing

Muscle Stimulation for Physical Function During Stem Cell Transplant

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
VA Office of Research and Development 46
Large-scale testing (Phase 3)Study completedNCT02181413
What this trial is testing

Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Takeda 656
Testing effectiveness (Phase 2)Study completedNCT01007292
What this trial is testing

YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

Who this might be right for
Non-Hodgkin's Lymphoma
Astellas Pharma Inc 43
Testing effectiveness (Phase 2)Study completedNCT01481272
What this trial is testing

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Polish Lymphoma Research Group 77
Not applicableWithdrawnNCT02225795
What this trial is testing

Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

Who this might be right for
Crohn's Disease
TriStar Health
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Not applicableActive Not RecruitingNCT05271630
What this trial is testing

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 69
Not applicableStudy completedNCT02452099
What this trial is testing

Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.

Who this might be right for
Multiple MyelomaLymphomasLeukemias
Maria Sklodowska-Curie National Research Institute of Oncology 150
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Large-scale testing (Phase 3)Study completedNCT00012051
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Commissie Voor Klinisch Toegepast Onderzoek 340
Testing effectiveness (Phase 2)Study completedNCT00599495
What this trial is testing

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)UnknownNCT03014102
What this trial is testing

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

Who this might be right for
ThrombocytopoietinHematopoietic Stem Cell MobilizationHematopoietic Stem Cell Transplantation
Hongnan Mo 50
Not applicableUnknownNCT04024618
What this trial is testing

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

Who this might be right for
Malignant Hematologic Neoplasm
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Large-scale testing (Phase 3)Ended earlyNCT05181540
What this trial is testing

The Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation

Who this might be right for
Hodgkin LymphomaNon Hodgkin Lymphoma
Angiocrine Bioscience 130
Next Page